These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31855781)

  • 1. Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors.
    Anwar MF; Khalid R; Hasanain A; Naeem S; Zarina S; Abidi SH; Ali S
    Comput Biol Chem; 2020 Feb; 84():107167. PubMed ID: 31855781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Cheminformatics-Molecular Docking Approach to Drug Discovery Against Viruses.
    Anwar MF; Khalid R; Hasanain A; Naeem S; Zarina S; Abidi SH; Ali S
    Infect Disord Drug Targets; 2020; 20(2):150-159. PubMed ID: 30345931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
    Lim SK; Othman R; Yusof R; Heh CH
    Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing and molecular docking of cyclic peptides against HCV NS3 protease.
    Masoud MS; Bukhari SA; Qasim M; Naqvi SAR; Ashfaq UA
    Pak J Pharm Sci; 2017 Sep; 30(5(Supplementary)):1965-1969. PubMed ID: 29105629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from
    Patil VS; Harish DR; Vetrivel U; Roy S; Deshpande SH; Hegde HV
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164341
    [No Abstract]   [Full Text] [Related]  

  • 6. Phylogenetic analysis, structure modeling and docking study of HCV NS3 protease for the identification of potent inhibitors.
    Zia A; Abbasi SW; Ahmad S; Zia M; Raza A
    Infect Genet Evol; 2018 Apr; 59():51-62. PubMed ID: 29391202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches.
    Ezat AA; Elshemey WM
    Life Sci; 2019 Jan; 217():176-184. PubMed ID: 30528183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
    El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
    Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
    J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs.
    Bilodeau F; Bailey MD; Bhardwaj PK; Bordeleau J; Forgione P; Garneau M; Ghiro E; Gorys V; Halmos T; Jolicoeur ES; Leblanc M; Lemke CT; Naud J; O'Meara J; White PW; Llinàs-Brunet M
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4267-71. PubMed ID: 23735741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and design of cyclic peptides as dengue virus inhibitors through structure-based molecular docking.
    Idrees S; Ashfaq UA
    Asian Pac J Trop Med; 2014 Jul; 7(7):513-6. PubMed ID: 25063278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach.
    Ashfaq UA; Jalil A; Ul Qamar MT
    Nat Prod Res; 2016 Aug; 30(16):1866-9. PubMed ID: 26274064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolones inhibit HCV by targeting its helicase.
    Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
    Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.
    Palanisamy N; Lennerstrand J
    Interdiscip Sci; 2018 Mar; 10(1):143-156. PubMed ID: 27311576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
    Mustafa G; Majid M; Ghaffar A; Yameen M; Samad HA; Mahrosh HS
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2317-2322. PubMed ID: 33832906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors.
    Saleh NA; Elshemey WM
    Life Sci; 2017 Oct; 187():58-63. PubMed ID: 28842311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.